UTA NURS5334 ADVANCED PHARMACOLOGY
TEST PAPER 2026 FINAL EXAM QUESTIONS
WITH ACCURATE SOLUTIONS GRADED A+
◉ Benzodiazepines and CNS depressants with acetaminophen-
hydrocodone. Answer: False, this could lead to respiratory
depression
◉ Buprenorphine for maintenance after opioid abuse. Answer:
Partial opioid agonist that activated opioid receptors but produces
less degree of euphoria and physical dependence compared to a full
agonist
◉ Naltrexone for maintenance after opioid abuse. Answer:
Naltrexone is a opioid antagonist that blocks the euphoric and
sedative effects of opioids.
◉ Side effects of Hydrocodone. Answer: Constipation, Respiratory
depression, Addiction
◉ MOA of Sumatriptan. Answer: Selective agonist for serotonin 5HT
receptors on intracranial blood vessels and sensory nerves of the
trigeminal system, causes VASOCONSTRICTION and reduces
neurogenic inflammation
,◉ Feverfew use. Answer: Migraine Prophylaxis
◉ Drugs that cannot be combined with Feverfew. Answer:
Antiplatlets, Anticoagulants, Increased risk of bleeding in patients
taking antiplatelets (Aspirin) and anticoagulants (Warfarin)
◉ Folic acid for Folic Acid Deficiency. Answer: Give 1-2mg/day PO
for a deficiency
◉ Folic acid for women of childbearing age. Answer: 400-800 mcg
daily
◉ Folic acid for pregnant women. Answer: 400-600 mcg/day
◉ Tacrolimus and Pimecrolimus cream use. Answer: Atopic
Dermatitis (Eczema)
◉ Safe drug classes in later pregnancy. Answer: Beta blockers
◉ Safe medications for pregnant women. Answer: Methyldopa and
Labetalol are the traditional agents of choice for pregnant women
, ◉ Methyldopa and Labetalol use in pregnancy. Answer: These drugs
have limited effects on uteroplacental and fetal hemodynamics and
do not adversely affect the fetus or neonate
◉ Anticholinergics for drooling in Parkinson's. Answer: True
◉ Medication for COPD with eosinophils 312. Answer: Salmeterol +
aclidinium + Budesonide
◉ COPD Group A. Answer: Bronchodilator
◉ COPD Group B. Answer: LABA + LAMA
◉ COPD Group E. Answer: LABA + LAMA
◉ Body fat percentage effect on lipid soluble drugs. Answer: The
higher the body fat percentage the more the plasma levels of lipid
soluble drugs will be reduced
◉ Lean mass decrease effect on water soluble drugs. Answer:
Increased
◉ Malnourished elderly patients and protein binding drugs. Answer:
Increase
TEST PAPER 2026 FINAL EXAM QUESTIONS
WITH ACCURATE SOLUTIONS GRADED A+
◉ Benzodiazepines and CNS depressants with acetaminophen-
hydrocodone. Answer: False, this could lead to respiratory
depression
◉ Buprenorphine for maintenance after opioid abuse. Answer:
Partial opioid agonist that activated opioid receptors but produces
less degree of euphoria and physical dependence compared to a full
agonist
◉ Naltrexone for maintenance after opioid abuse. Answer:
Naltrexone is a opioid antagonist that blocks the euphoric and
sedative effects of opioids.
◉ Side effects of Hydrocodone. Answer: Constipation, Respiratory
depression, Addiction
◉ MOA of Sumatriptan. Answer: Selective agonist for serotonin 5HT
receptors on intracranial blood vessels and sensory nerves of the
trigeminal system, causes VASOCONSTRICTION and reduces
neurogenic inflammation
,◉ Feverfew use. Answer: Migraine Prophylaxis
◉ Drugs that cannot be combined with Feverfew. Answer:
Antiplatlets, Anticoagulants, Increased risk of bleeding in patients
taking antiplatelets (Aspirin) and anticoagulants (Warfarin)
◉ Folic acid for Folic Acid Deficiency. Answer: Give 1-2mg/day PO
for a deficiency
◉ Folic acid for women of childbearing age. Answer: 400-800 mcg
daily
◉ Folic acid for pregnant women. Answer: 400-600 mcg/day
◉ Tacrolimus and Pimecrolimus cream use. Answer: Atopic
Dermatitis (Eczema)
◉ Safe drug classes in later pregnancy. Answer: Beta blockers
◉ Safe medications for pregnant women. Answer: Methyldopa and
Labetalol are the traditional agents of choice for pregnant women
, ◉ Methyldopa and Labetalol use in pregnancy. Answer: These drugs
have limited effects on uteroplacental and fetal hemodynamics and
do not adversely affect the fetus or neonate
◉ Anticholinergics for drooling in Parkinson's. Answer: True
◉ Medication for COPD with eosinophils 312. Answer: Salmeterol +
aclidinium + Budesonide
◉ COPD Group A. Answer: Bronchodilator
◉ COPD Group B. Answer: LABA + LAMA
◉ COPD Group E. Answer: LABA + LAMA
◉ Body fat percentage effect on lipid soluble drugs. Answer: The
higher the body fat percentage the more the plasma levels of lipid
soluble drugs will be reduced
◉ Lean mass decrease effect on water soluble drugs. Answer:
Increased
◉ Malnourished elderly patients and protein binding drugs. Answer:
Increase
